Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0759
D

Medication Error Rate Exceeds 5% Due to Incorrect Timing of Administration

Elsmere, Kentucky Survey Completed on 05-22-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to maintain a medication error rate below five percent, as evidenced by two errors out of 33 observed opportunities, resulting in a 6.06% error rate. Specifically, an LPN prepared and administered two medications—Atorvastatin 20 mg and Loratadine 10 mg—to a resident during the morning medication pass, despite both medications being ordered for administration at bedtime. The LPN acknowledged the error, stating awareness that the medications were scheduled for nighttime and that they were pulled in error. The contracted pharmacist confirmed that while no immediate harm was expected, the efficacy of Atorvastatin could be reduced when given in the morning, and Loratadine could cause daytime drowsiness. The pharmacist also noted the risk of exceeding the maximum daily dose if the medication was administered again at bedtime. Both the DON and the Administrator stated their expectations that medications be administered according to physician orders and facility policy.

An unhandled error has occurred. Reload 🗙